ArticleClinical drug investigation2023

Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System.

Toru Ogura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.